For immediate release |
18 November 2013 |
Futura Medical plc
("Futura" or "the Company")
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer |
Futura Medical PLC |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
Yes |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
||||
An event changing the breakdown of voting rights |
||||
Other (please specify): |
|
|||
3. Full name of person(s) subject to the |
BlackRock, Inc. |
|||
4. Full name of shareholder(s) |
|
|||
5. Date of the transaction and date on |
13th November 2013 |
|||
6. Date on which issuer notified: |
15th November 2013 |
|||
7. Threshold(s) that is/are crossed or |
Holding has gone below 5% |
|||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
||||||||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||||||||
GB0033278473 |
3,812,500 |
3,812,500 |
N/A |
N/A |
N/A |
N/A |
Below 5% |
|||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
|
|
|
|
|
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights
|
|||||||||||
|
|
|
|
|
Nominal |
Delta |
||||||||||
|
|
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
N/A |
Below 5% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
BlackRock Investment Management (UK) Limited - N/A (Below 5%) |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
|
|
11. Number of voting rights proxy holder will cease |
|
|
12. Date on which proxy holder will cease to hold |
|
|
|
||
|
BlackRock Regulatory Threshold Reporting Team |
|
14. Contact name: |
Duncan Murray |
|
15. Contact telephone number: |
020 7743 3334 |
|